Cargando…
PSAT232 Understanding the Duration of Zinc 8 Transporter Antibody Seropositivity
BACKGROUND: Since their recent discovery of zinc transporter 8 antibodies (ZnT8A) by Wenzlau et al. in 2007, the relevance and clinical utility of this marker has been in question. Some recent reports have shown a wide potential for both diagnostic as well as prognostic clinical applications in T1DM...
Autores principales: | Chavez, Hilda Merino, Pena, Ernesto Munoz, Suryanarayanan, Sowmya, Yau, Hanford, Paniagua, Gabriela Zuniga, Botero Suarez, Carlos S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624882/ http://dx.doi.org/10.1210/jendso/bvac150.746 |
Ejemplares similares
-
ODP232 Postoperative Glycemic Management of Children Undergoing Pancreatectomy with Islet Autotransplantation
por: Grimbly, Chelsey, et al.
Publicado: (2022) -
PSAT277 Glucocorticoid Therapy for Management of Hypoglycemia in the context of Non-Islet Cell Tumor-Induced Hypoglycemia
por: Agarwal, Rahul, et al.
Publicado: (2022) -
PSAT231 Perceived Cognitive Function Is Associated With Adherence to Diabetes Self-Management Behaviors Among Breast Cancer Survivors
por: Itty, Jennifer, et al.
Publicado: (2022) -
PSAT035 COVID-19 Infection Increases DKA and mortality- A Harbinger for Increased Acute Diabetes Emergencies in the Future?
por: Firek, Anthony, et al.
Publicado: (2022) -
SAT097 Investigation Of The Minimum Duration Needed To Estimate The Percentile Values For Target Duration In Ambulatory Glucose Profile
por: Takeishi, Soichi, et al.
Publicado: (2023)